Pharma supply shortages drive calls for more integrated supply chains
Drug maker Pfizer sounded the alarm on 11 June that it would be running out ...
LOW: INVESTOR DAY UPS: CYCLICAL UPSIDEATSG: 'GO-SHOP' UPDATEXPO: ALL-TIME HIGH ON TAKEOVER TALKMAERSK: DIRECTIONGM: DONE WITH ITSTLA: LSP BATTERY JVDSV: ANOTHER BULL BA: BACK ONCHRW: STRENGTH AHEAD OF INVESTOR DAYCHRW: UPGRADEWMT: TAKING PROFIT DHL: ANTITRUST SCRUTINYFWRD: UPDATE
LOW: INVESTOR DAY UPS: CYCLICAL UPSIDEATSG: 'GO-SHOP' UPDATEXPO: ALL-TIME HIGH ON TAKEOVER TALKMAERSK: DIRECTIONGM: DONE WITH ITSTLA: LSP BATTERY JVDSV: ANOTHER BULL BA: BACK ONCHRW: STRENGTH AHEAD OF INVESTOR DAYCHRW: UPGRADEWMT: TAKING PROFIT DHL: ANTITRUST SCRUTINYFWRD: UPDATE
CNBC reports:
KEY POINTS
– Moderna is said to have asked the FDA to allow it to put additional doses in its vaccine vials.
– The move is aimed at alleviating a bottleneck in Covid-19 vaccine manufacturing.
– The change would add up to five doses to the 10-dose vials.
Moderna has asked the U.S. Food and Drug Administration for permission to fill its Covid-19 vaccine vials with up to five additional doses to ease a bottleneck in manufacturing, according to a person familiar with the matter.
The change would allow Moderna to put 15 doses in the same size vials now cleared to hold 10, alleviating pressure on the part of the manufacturing process known as fill/finish, said the person, who declined to be named because the application isn’t yet public.
The availability of Covid-19 vaccines has been a source of frustration since their clearance in the U.S. in mid-December. While the pace of administration has picked up to more than 1 million a day on average, constrained supply has hindered states’ ability to operate mass vaccination sites. As of Friday, the U.S. had distributed 49.2 million doses, and 27.9 million had been administered, according to the Centers for Disease Control and Prevention.
To read the full post, please click here.
Comment on this article